ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,033,000 | -45.2% | 270,000 | 0.0% | 0.07% | -37.1% |
| Q4 2019 | $3,713,000 | +15.7% | 270,000 | 0.0% | 0.10% | -0.9% |
| Q3 2019 | $3,208,000 | -15.1% | 270,000 | 0.0% | 0.11% | -7.8% |
| Q2 2019 | $3,777,000 | -21.8% | 270,000 | 0.0% | 0.12% | -30.7% |
| Q1 2019 | $4,828,000 | +13.7% | 270,000 | 0.0% | 0.17% | -11.7% |
| Q4 2018 | $4,247,000 | – | 270,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $17,919,000 | 4.17% |
| RA Capital Management | 12,315,213 | $54,064,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $30,508,000 | 0.54% |
| Avidity Partners Management LP | 3,781,798 | $16,602,000 | 0.45% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,366,564 | $5,999,000 | 0.41% |
| Casdin Capital, LLC | 3,215,434 | $14,116,000 | 0.36% |
| Vivo Capital, LLC | 1,325,736 | $5,820,000 | 0.25% |
| Artal Group S.A. | 1,803,858 | $7,919,000 | 0.16% |
| Virtus ETF Advisers LLC | 44,471 | $195,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 752,108 | $3,302,000 | 0.08% |